Glooko
Palo Alto, US · Founded 2010 · Delaware corporation · 3 known investors
Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
Digital HealthHealthtechSaaS
Founders & leadership
CD
Clay DavidsoninExecutive
PM
Prakash MenoninExecutive
EM
Ed MarshallExecutive
DP
David PassExecutive
AH
Adam HameedExecutive
MB
Mark BeuclerinExecutive
RJ
Russ JohannessonExecutive
KS
Komathi StemExecutive
SL
Steve LienExecutive
CD
Christina DickersonExecutive
Board
WH
CB
Investors · 3
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 of 3 rounds · 2021–2024
▶$124MofferedAug 2024 · Other Health CareRule 506(b)
▶$124MofferedAug 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Clay DavidsonExecutive Officer
- Prakash MenonExecutive Officer
- Wende HuttonDirector
- Ed MarshallExecutive Officer
- David PassExecutive Officer
- Charles BooradyDirector
- Adam HameedExecutive Officer
- Mark BeuclerExecutive Officer
- Simon ChongDirector
- Enrique ConternoDirector
- Russ JohannessonExecutive Officer
- Tracy BahlDirector
- Offering amount
- $124M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$67MofferedAug 2023 · Other Health CareRule 506(b)
▶$67MofferedAug 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Charles BooradyDirector
- Komathi StemExecutive Officer
- Steve LienExecutive Officer
- Ed MarshallExecutive Officer
- Tracy BahlDirector
- Christina DickersonExecutive Officer
- Alfonso ZuluetaDirector
- Clay DavidsonExecutive Officer
- Yogen DalalDirector
- Simon ChongDirector
- Prakash MenonExecutive Officer
- Wende HuttonDirector
- Russ JohannessonExecutive Officer, Director
- Offering amount
- $67M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedMar 2021 · 11 investors · Other Health CareRule 506(b)
▶$30MraisedMar 2021 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yogen DalalDirector
- Zach HendersonExecutive Officer
- Steve LienExecutive Officer
- Russ JohannessonExecutive Officer, Director
- Clay DavidsonExecutive Officer
- Komathi SternExecutive Officer
- Charles BooradyDirector
- Mike DohertyDirector
- Simon ChongDirector
- Wende HuttonDirector
- Offering amount
- $35M
- Amount sold
- $30M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Diabetes180 shared keywordsThe American Diabetes Association is a nonprofit organization focused on diabetes prevention, research, advocacy, and education, providing resources, community programs, and support for people living with diabetes and prediabetes in the United States. It also advocates for policy such as affordable insulin and hosts scientific and technology conferences.
DexCom101 shared keywordsDexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.
Walgreens79 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Companies competing with Glooko for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Glooko do?
- Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring. It serves healthcare providers and clinics managing people with diabetes, integrating with device makers such as Abbott, Dexcom, Insulet, and Tandem, and with EHR systems including Epic and Oracle Health.
- Who are Glooko's investors?
- Glooko's investors include Canaan Partners, Health Catalyst Capital, Samsung Next.
- How much funding has Glooko raised?
- Glooko has disclosed $30M raised across 1 of its 3 known rounds.
- Where is Glooko headquartered?
- Glooko is headquartered in Palo Alto, US.